Antoîne Italiano

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial”.

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30321-1

N/A

5.7DataRank · unranked

527 citations

Ulrik Lassen, Élena Elez, Antoîne Italiano, Giuseppe Curigliano, Milind Javle +14 more

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

Nature Medicine(2023)10.1038/s41591-023-02321-8

N/A

4.1DataRank · unranked

307 citations

Robert J. Kreitman, Zev A. Wainberg, Anas Gazzah, Ulrik Lassen, Alexander Stein +18 more

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00382-4

N/A

2.2DataRank · unranked

73 citations

Philippe A. Cassier, Marwan Fakih, Steven Kao, Dorte Nielsen, Antoîne Italiano +17 more

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

International Journal of Cancer(2021)10.1002/ijc.33861

N/A

1.9DataRank · unranked

62 citations

Jean‐Yves Blay, Irene García, Johann S. De Bono, Christophe Le Tourneau, Víctor Moreno +25 more

Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study

European Journal of Cancer(2021)10.1016/j.ejca.2021.03.039

N/A

1.3DataRank · unranked

47 citations

Antoîne Italiano, Emannuelle Bompas, María Rios, Nicolas Penel, Olivier Mir +18 more

B cells are associated with survival and immunotherapy response in sarcoma

Nature(2020)10.1038/s41586-019-1906-8

N/A

1.1DataRank · unranked

1854 citations

Aurélien de Reyniès, Emily Z. Keung, Tom Wei‐Wu Chen, Cheng‐Ming Sun, Julien Caldéraro +24 more

794 Safety and efficacy results from a phase 1/1b study of intratumoral MK-4621, a retinoic acid-inducible gene I (RIG-I) agonist, plus intravenous pembrolizumab in patients with advanced solid tumors

(2020)10.1136/jitc-2020-sitc2020.0794

N/A

0DataRank · unranked

4 citations

Caroline Gaudy‐Marqueste, Martin Wermke, Antoîne Italiano, Emanuela Romano, Aurélien Marabelle +7 more

542P Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients

Annals of Oncology(2020)10.1016/j.annonc.2020.08.656

N/A

0DataRank · unranked

3 citations

David S. Hong, Andrew Briggs, Jesús García‐Foncillas, Ulrik Lassen, Gilles Vassal +9 more

Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin

Cancer(2020)10.1002/cncr.33145

N/A

0DataRank · unranked

62 citations

Christine Alewine, Idrees Mian, Anna Spreafico, Lillian L. Siu, Carlos Gomez‐Roca +13 more

Translational Aspects of Epithelioid Sarcoma: Current Consensus

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2174

N/A

0DataRank · unranked

15 citations

Sophie Postel‐Vinay, Robert Nakayama, Noah Berlow, Andrea Bolzicco, Vincenzo Cerullo +21 more

Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.11.018

N/A

0DataRank · unranked

5 citations

Natraj Reddy Ammakkanavar, Antoine Hollebecque, Dae Ho Lee, Takafumi Koyama, Philippe A. Cassier +20 more